Larvol Delta - SWISS-OPTICOV-OPtimisation-of-Antiviral-Therapy-in-Immunocompromised-COVID19-Patients-a-Randomized-Factorial-Controlled-Strategy-Trial

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://clinicaltrials.gov/ct2/show/NCT07406217

Feb 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next